Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kaleido logo — Kaleido, insulin pump therapy designed to help you live life...

Kaleido

Kaleido, insulin pump therapy designed to help you live life on your own terms.

Founded 2013 The Netherlands The Netherlands 195 employees Series D Total: $170.40M Health Care, Medical Devices

General Information

Company Name Kaleido
Founded Year 2013
Location The Netherlands The Netherlands +1
Employees 195
Industries Health Care, Medical Devices
Funding Stage Series D
Social

Get notified when Kaleido moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kaleido

Kaleido, the pioneering insulin pump therapy by ViCentra BV, embodies their slogan: "Kaleido, insulin pump therapy designed to help you live life on your own terms." Founded in 2013 in Utrecht, The Netherlands, the company is revolutionizing the healthcare industry by focusing on products that prioritize user experience.

Operating in the Health Care and Medical Devices sectors, ViCentra BV is dedicated to minimizing the daily challenges faced by individuals with diabetes. Kaleido stands out for its patient-centric approach, aiming to reduce the disease's impact on everyday life with its innovative design and functionality.

Recently, the company secured a $13.00 million Series D investment on 08 January 2026, backed by strategic investors including ROM Utrecht Region, Innovation Industries, and Venturing Tech. This funding round marks a significant milestone, underscoring investor confidence in Kaleido's potential to lead advancements in diabetic care.

Taxonomy: Insulin Pump Therapy, Diabetes Management, Innovative Healthcare Products, User-Centric Design, Healthcare Product Commercialization, Early Stage Commercial Company, Human-Centric Design, Simplified Healthcare Solutions

Services & Products

Automated Insulin Delivery
Diabetes Data Insights
Customizable Wearable Pumps
Healthcare Consultation Support

Target Customers

Adults with Type 1 Diabetes Healthcare Providers Caregivers of Diabetic Patients

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 3
Investor Investor
•••• •••• 		08 Jan 2026
Series D •••••• 5
Investor Investor Investor Investor
•••• •••• 		05 Sep 2025
Series C •••••• 4
Investor Investor
•••• •••• 		16 Dec 2021
Venture Round •••••• 5
Investor Investor Investor Investor
•••• •••• 		08 Jul 2020
Series B •••••• 1 •••• •••• 20 Jan 2016

View All 6 Funding Rounds

Latest News

View All
Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump — Eu-startups
Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump
Eu-startups Sep 05, 2025
Dutch Men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through... — Eu-startups
Dutch Men’s health startup Fellos lands €2 million to tackle sensitive issues like ED and PE through telehealth
Eu-startups Oct 07, 2025
London-based GHO Capital boosts healthcare fund size by 25% to €2.5 billion — Eu-startups
London-based GHO Capital boosts healthcare fund size by 25% to €2.5 billion
Eu-startups Oct 28, 2025
ViCentra secures $13M to accelerate growth and advance next-gen insulin system — Tech
ViCentra secures $13M to accelerate growth and advance next-gen insulin system
Tech Jan 08, 2026

Kaleido Alternatives & Competitors

View All Alternatives
Kaleido vs
Hedia
Hedia Denmark

Our vision is to improve quality of life for people with diabetes and make the best diabetes managem...

Seed
43 employees
AI, Life Sciences
Compare Kaleido vs Hedia
Kaleido vs
VitalAire Diabetes South Africa
VitalAire Diabetes South Africa South Africa

We provide innovative, superior healthcare solutions to healthcare professionals in Africa.

13 employees
E-Commerce, Health Care
Compare Kaleido vs VitalAire Diabetes South Africa
Kaleido vs
Kaleido Corporation
Kaleido Corporation Canada

Shaping the future through inspiration, education, and growth, in the never-ending pursuit of excell...

3 employees
Also compare with: Kaleido vs OneTwo Analytics OneTwo Analytics View all alternatives

FAQ About Kaleido

Kaleido, insulin pump therapy designed to help you live life on your own terms.
Kaleido was founded in 2013.
Kaleido is headquartered in The Netherlands.
Kaleido operates in the following industries: Health Care, Medical Devices.
Kaleido has approximately 195 employees.
Kaleido has completed 6 funding rounds, raising a total of $170.40M. The latest funding stage is Series D.
Kaleido offers: Automated Insulin Delivery, Diabetes Data Insights, Customizable Wearable Pumps, Healthcare Consultation Support.
Top alternatives and competitors to Kaleido include Hedia, VitalAire Diabetes South Africa, Kaleido Corporation, OneTwo Analytics, Advanx Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kaleido and Hedia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kaleido and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy